Immunomodulation of Rat Endometriotic Implant Growth and Protein Production
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
PROBLEM: The immune system has been implicated in the pathophysiology of endometriosis. To determine if modulation of the immune system influences endometriotic implant growth and protein production, the following experiment was conducted. METHOD: Female rats with surgically induced endometriosis were treated with either the immunosuppressive agent pentoxifylline (Pent; 5 mg/kg BW; N = 16) or a vehicle (N = 16) for 7 consecutive days, then killed. Twenty‐four hours before death, 8 animals from each group were injected intraperitoneally with the immunostimulatory agent lipopolysaccharide (LPS; 200 Hg/kg BW). At death, endometriotic implants were measured and protein production assessed by two‐dimensional polyacrylamide gel electrophoresis. RESULT: Pentoxifylline significantly (P < 0.001) reduced endometriotic implant size (2.15 ± 0.65 mm 2 vs. 17.13 ± 1.98 mm 2) whereas LPS was without effect (18.32 ± 2.57 mm 2 vs. 17.13 ± 1.98 mm 2). Pentoxifylline also suppressed production of a portion of the proteins that comprise the implant specific group of proteins, ENDO‐2, whereas LPS induced the production of two additional ENDO‐2 proteins. CONCLUSION: Immunomodulatory agents can modulate rat endometriotic implant growth and production of implant‐specific proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vernon, M. W., Beard, J. S., Graves, K., & Wilson, E. A. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49814-6 · Cited by 204
Self-citationAngiogenic activity of peritoneal fluid from women with endometriosis
Oosterlynck, D. J., Meuleman, C., Sobis, H., Vandeputte, M., & Koninckx, P. R. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55859-2 · Cited by 182
Cited by
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Treating endometriosis as an autoimmune disease
Nothnick, W. B. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01878-7 · Cited by 276
Self-citationIs there an association between autoimmunity and endometriosis?
Eisenberg, V. H., Zolti, M., & Soriano, D. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.01.005 · Cited by 164
Medical management of endometriosis-associated pain
Mahutte, N. G., & Arici, A. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00057-8 · Cited by 68
“Studies of pentoxifylline (an anti–tumor necrosis factor therapy) in animals have shown regression of implants [102] and reversal of surgically induced endometriosisassociated infertility [103].”
BackgroundNew treatment strategies and emerging drugs in endometriosis
Streuli, I., de Ziegler, D., Borghese, B., Santulli, P., Batteux, F., & Chapron, C. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.668885 · Cited by 27
“Pentoxifylline, a xanthine derivative that acts as a competitive nonselective phosphodiesterase inhibitor, has also been shown to inhibit the production of TNF-a by macrophages, influence the production of mediators of inflammation and to alter the responsiveness of immunocompetent cells to inflammatory stimuli [124,1…”
Background
Metadata
- Authors
- Nothnick, W. B., Curry, T. E., & Vernon, M. W.
- Venue
- American Journal of Reproductive Immunology
- Publisher
- Wiley
- Published
- 1994-03-04
- Volume
- 31
- Issue
- 2-3
- Pages
- 151-162
- ISSN
- 0271-7352 (ISSN-L)
- 1046-7408
- 1600-0897
- OpenAlex
- W2090152451
- Cited by
- 68
- References
- 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunomodulation of Rat Endometriotic Implant Growth and Protein Production. https://app.cochat.ai/papers/10.1111/j.1600-0897.1994.tb00860.x
- The paper
- Nothnick, W. B., Curry, T. E., & Vernon, M. W. (1994). Immunomodulation of Rat Endometriotic Implant Growth and Protein Production. American Journal of Reproductive Immunology. https://doi.org/10.1111/j.1600-0897.1994.tb00860.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.